Meredith Schultz, MD, MS

Observer
DISC Type : ci

Vice President, Global Medical Expert - Gene Therapies at Ultragenyx

Madison, Wisconsin, United States

Overview

Meredith Schultz is the Vice President, Global Medical Expert for Gene Therapies at Ultragenyx. A board-certified pediatric neurologist with over 17 years of experience, she is an expert in treating rare neurogenetic disorders and leading clinical development for novel gene therapies for conditions like Rett syndrome and spinal muscular atrophy, drawing on her advanced genomics education from Johns Hopkins.

She was a Principal Investigator on the pivotal clinical trials for Zolgensma, a revolutionary gene therapy for spinal muscular atrophy.

Personality Overview

Value Driven

Assertive

Curious

They are generally good communicators and can be hard to convince.  They are likely to ask many questions and look heavily for supporting information. They can sound friendly and charming but can quickly change gears to become inquisitive and probing.

Topics They Care About

Gene Therapy Trials
Her career is focused on leading clinical development and medical affairs for AAV-based gene therapies at companies like Ultragenyx, Taysha, and Novartis.
Rare Neurologic Disorders
Specializes in treating rare and neurogenetic conditions, describing it as one of her passions, with a specific focus on Rett syndrome and spinal muscular atrophy (SMA).
Pediatric Neurology
A board-certified pediatric neurologist with extensive clinical experience treating children with complex neuromuscular and neurodegenerative disorders.

Media Appearances

Ultragenyx Announces Positive Longer-Term Data Demonstrating Treatment with UX111 Gene Therapy. Featured in Bakersfield.com (Associated Press)

See Now

Work History

4-2025
Vice President, Global Medical Expert - Gene Therapies at Ultragenyx
2-2024 - 1-2025
Chief Medical Officer at Taysha Gene Therapies
12-2023 - 2-2024
Senior Vice President, Head of Clinical Development and Medical Affairs at Taysha Gene Therapies
7-2021 - 12-2023
Vice President, Sector Lead, Early Stage at Asklepios BioPharmaceutical, Inc. (AskBio)
1-2021 - 7-2021
Executive Medical Director, Head of Gene Therapies Translational Medicine at Novartis Gene Therapies

Education

2018 - 2020
Individualized Genomics and Health from Johns Hopkins University Advanced Academic Programs
2003 - 2007
Doctor of Medicine - MD from University of Wisconsin-Madison

More Information

Social Presence :

Prographics :

Exp : 18 Location : Madison, Wisconsin, United States Job Level : Senior Designation : Vice President, Global Medical Expert - Gene Therapies at Ultragenyx
URL has been copied!

Insights For Selling To Meredith

During A Call Or A Meeting

DO's

  • Share testimonials from known people and give multiple examples of product value
  • Build rapport, it will come handy to handle hard questions later
  • Focus on immediate action-items rather than the larger goals

DONT's

  • Avoid making offhand commitments
  • Don’t try to rush them into a decision, provide all necessary information first
  • Don’t be too objective but make sure to pad your storytelling with data points

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Meredith is

  • Proven value, strong testimonials are important to them, relationships will have some weightage.
  • Will you ever get a clear answer from Meredith

  • They are practical and friendly, don't expect a clear-cut response often.

Insights For Deal Planning

    How fast (or slow) will Meredith move?

  • They like to be detailed and take their time to arrive at decisions.
  • Can Meredith take some risk or not?

  • They evaluate their decisions systematically and are less likely to take risks.

You And Meredith

Personality Compatibility


Other Ultragenyx Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.